Analysis of current status and treatment status and influencing factors of lung cancer with chronic obstructive pulmonary disease in the elderly
CSTR:
Author:
Affiliation:

(Department of Respiratory and Critical Care Medicine, Peking University People′s Hospital, Beijing 100044, China)

Clc Number:

Fund Project:

This work was supported by the Research and Development Fund of PekingUniversity People's Hospital(RDJP2024-21).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the current status and related influencing factors of chronic obstructive pulmonary disease (COPD) specific treatment in elderly patients with lung cancer (LC) and COPD (LC-COPD) comorbidity. Methods A total of 210 elderly LC patients admitted to Peking University People′s Hospital from January to May 2025 were enrolled. Demographic data, clinical information, and imaging findings were collected. All patients underwent comprehensive pulmonary function tests, and were divided into a LC-COPD group and a LC group based on whether COPD was present. The current status of specialized COPD treatment was analyzed in the LC-COPD patients, and the LC-COPD group was further assigned into a treated subgroup and an untreated subgroup. SPSS 26.0 statistics was used for data analysis. Data comparisons between two groups was conducted using independent samples t test orχ2 test depending on data type. Logistic regression model was employed to analyze influencing factors for LC-COPD comorbidity and for whether receiving specialized COPD treatment among the LC-COPD patients. Results Among the 210 elderly LC patients, pulmonary function tests confirmed that 128 patients (60.95%) also had COPD. Logistic regression analysis revealed that male (OR=2.102,95%CI 1.278-3.459; P=0.004), smoking index ≥400 cigarettes/year (OR=1.560,95%CI 1.067-2.282; P=0.022) and emphysema (OR=1.725,95%CI 1.198-2.483; P=0.004) were risk factors for LC-COPD comorbidity in elderly LC patients. Of the 128 patients with LC-COPD, 44 patients received COPD-related treatment, including 22 patients who followed the preferred treatment regimens recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), while the remaining 22 patients did not adhere to the guideline recommendations. With whether LC-COPD patients received COPD treatment as the dependent variable, logistic regression analysis revealed that GOLD stage 3-4 (OR=2.168,95%CI 1.160-4.052; P=0.016), dyspnea index score ≥2 points (OR=1.738,95%CI 1.234-2.450; P=0.002), COPD assessment test score ≥10 points (OR=1.972,95%CI 1.199-3.244; P=0.008), physical status score ≥2 points (OR=1.404,95%CI 1.060-1.858; P=0.018) and anxiety (OR=1.335,95%CI 1.091-1.634; P=0.005) were influencing factors for receiving specialized COPD treatment in LC-COPD patients. Conclusion Elderly LC patients exhibit high comorbidity rate of COPD. Lung function assessment should be particularly emphasized among male patients, those with a smoking index ≥400 cigarettes/year and those with emphysema. Additionally, the rate of specialized COPD treatment is quite low among patients with LC-COPD comorbidity, and there are considerable instances of non-adherence to prescribed therapies. Patients with severe COPD, poor physical condition, or comorbid anxiety are more likely to receive targeted COPD treatment. It is recommended that clinicians should conduct comprehensive COPD assessments and provide appropriate pharmacological interventions for patients with LC-COPD comorbidity.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 19,2025
  • Revised:
  • Adopted:
  • Online: August 05,2026
  • Published:
Article QR Code